Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

MHRA authorisation of new treatment for chronic kidney disease associated with diabetes

March 9, 2022 Research and Development

The MHRA has authorised the use of Kerendia® (finerenone) (10mg or 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) …
News

First smart connected insulin pens made available on NHS

March 2, 2022 Research and Development

Today, Novo Nordisk will launch the first smart connected insulin pens to be made available on NHS prescription. The pens, …
News

Fera Pharmaceuticals receives Orphan Drug Designation from FDA for sickle cell treatment

March 2, 2022 Research and Development

The FDA has granted an Orphan Drug Designation for naproxcinod for the treatment of sickle cell disease, which affects an …
News

HPV vaccines could mean only one smear test a lifetime

March 2, 2022 Research and Development

A leading scientist has said that women who have the HPV vaccine may need only one smear test to prevent …
News

FDA share new trial guidelines to further cancer therapy development

March 2, 2022 Research and Development

The FDA has issued three recommendations to industry for clinical trials, to support US President Joe Biden’s relaunch of the …
News

93% accuracy in new Alzheimer’s test, according to international study

February 23, 2022 Research and Development

The Washington University School of Medicine in St Louis has developed a blood test for Alzheimer’s disease which has proved …
News

Extra blood test could help detect risk of death from heart attack

February 23, 2022 Research and Development

Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of …
News

FDA places gene therapy trial on hold

February 23, 2022 Research and Development

Homology Medicines has shared that the FDA has placed its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria …
News

NICE recommends Albireo’s Bylvay (odevixibat) for all PFIC types

February 23, 2022 Research and Development

NICE has issued guidance that recommends Bylvay (odevixibat) for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC) …
News

Invitae launches first CE-IVD cancer testing kits in Europe

February 16, 2022 Research and Development

Invitae, leading medical genetics company, announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe.With this development, the company …
News

AstraZeneca COVID-19 vaccine’s short shelf life inhibits rollout to poor countries

February 16, 2022 Research and Development

According to officials and WHO documents, the short shelf life of the AstraZeneca COVID-19 vaccine is complicating the rollout to …
News

Scientists possibly cure HIV in first-time breakthrough for virus

February 16, 2022 Research and Development

An American research team appear to have cured HIV in a woman for the first time, making her the third …
News

Moderna launch Omicron-specific UK vaccine study

February 16, 2022 Research and Development

Around 3,000 British volunteers are being sought to take part in a new study for Moderna’s Omicron booster vaccine. The …
News

FDA investigate possible increased risk of death with lymphoma medicine

February 9, 2022 Research and Development

The FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). The administration is continuing …
News

SaNOtize breakthrough treatment 99% effective against COVID-19

February 9, 2022 Research and Development

SaNOtize and Glenmark Pharmaceuticals Limited have announced successful results of their Phase III clinical trials, as well as the approval …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026